Shen HC - Search Results

1

[Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].

Shen HC, Wang XW, Liu YG. Shen HC, et al. Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2498-503. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080633 Chinese.

2

Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.

Shen H, Hu D, Du J, Wang X, Liu Y, Wang Y, Wei JM, Ma D, Wang P, Li L. Shen H, et al. Eur J Pharmacol. 2008 Dec 28;601(1-3):23-9. doi: 10.1016/j.ejphar.2008.10.035. Epub 2008 Oct 28. Eur J Pharmacol. 2008. PMID: 18983839

3

A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.

Wang G, Dong W, Shen H, Mu X, Li Z, Lin X, Liu Y, Du J. Wang G, et al. Eur J Cardiothorac Surg. 2011 Jun;39(6):1028-32. doi: 10.1016/j.ejcts.2011.01.023. Epub 2011 Mar 4. Eur J Cardiothorac Surg. 2011. PMID: 21376622

4

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.

Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J. Yang M, et al. Eur J Cancer. 2013 Feb;49(3):604-15. doi: 10.1016/j.ejca.2012.09.031. Epub 2012 Oct 22. Eur J Cancer. 2013. PMID: 23099007 Review.

5

High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer.

Zhang T, Meng L, Dong W, Shen H, Zhang S, Liu Q, Du J. Zhang T, et al. Med Oncol. 2013;30(3):605. doi: 10.1007/s12032-013-0605-9. Epub 2013 May 21. Med Oncol. 2013. PMID: 23690269

6

Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses.

Dong W, Qiu C, Shen H, Liu Q, Du J. Dong W, et al. Int J Med Sci. 2013 Aug 9;10(10):1314-20. doi: 10.7150/ijms.6538. eCollection 2013. Int J Med Sci. 2013. PMID: 23983591 Free PMC article.

7

Evaluation of preoperative hematologic markers as prognostic factors and establishment of novel risk stratification in resected pN0 non-small-cell lung cancer.

Zhang T, Jiang Y, Qu X, Shen H, Liu Q, Du J. Zhang T, et al. PLoS One. 2014 Oct 31;9(10):e111494. doi: 10.1371/journal.pone.0111494. eCollection 2014. PLoS One. 2014. PMID: 25360716 Free PMC article.

8

Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.

Ma H, Wang L, Zhang T, Shen H, Du J. Ma H, et al. Tumour Biol. 2016 Jan;37(1):1341-7. doi: 10.1007/s13277-015-3886-0. Epub 2015 Aug 22. Tumour Biol. 2016. PMID: 26293896

9

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.

Sun H, Hu P, Shen H, Dong W, Zhang T, Liu Q, Du J. Sun H, et al. PLoS One. 2015 Dec 14;10(12):e0144663. doi: 10.1371/journal.pone.0144663. eCollection 2015. PLoS One. 2015. PMID: 26656866 Free PMC article.

10

ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response.

Shen H, Wang L, Zhang J, Dong W, Zhang T, Ni Y, Cao H, Wang K, Li Y, Wang Y, Du J. Shen H, et al. Oncol Rep. 2017 Feb;37(2):761-767. doi: 10.3892/or.2016.5337. Epub 2016 Dec 28. Oncol Rep. 2017. PMID: 28035404 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters